Obagi Nu-Derm System Normal-Oily Skin Transformation
HYDROQUINONE, HOMOSALATE, OCTISALATE, ZINC OXIDE · KIT · Obagi Cosmeceuticals LLC
Obagi Nu-Derm System Normal-Oily Skin Transformation is a kit containing hydroquinone, homosalate, octisalate, zinc oxide. Manufactured by Obagi Cosmeceuticals LLC.
Key Facts
- Brand Name
- Obagi Nu-Derm System Normal-Oily Skin Transformation
- Generic Name
- HYDROQUINONE, HOMOSALATE, OCTISALATE, ZINC OXIDE
- NDC Code (Product)
62032-912- Manufacturer
- Obagi Cosmeceuticals LLC
- Dosage Form
- KIT
- Marketing Status
- Marketing Start
- 06/25/2021
Recall History
No Recall HistoryFrequently Asked Questions
What is Obagi Nu-Derm System Normal-Oily Skin Transformation used for?
Obagi Nu-Derm System Normal-Oily Skin Transformation contains HYDROQUINONE, HOMOSALATE, OCTISALATE, ZINC OXIDE. It is a kit taken as directed. Consult your doctor for specific uses.
Is Obagi Nu-Derm System Normal-Oily Skin Transformation a controlled substance?
Obagi Nu-Derm System Normal-Oily Skin Transformation is not classified as a controlled substance by the DEA.
What is the generic name for Obagi Nu-Derm System Normal-Oily Skin Transformation?
The generic name for Obagi Nu-Derm System Normal-Oily Skin Transformation is HYDROQUINONE, HOMOSALATE, OCTISALATE, ZINC OXIDE. There are 5 other brand versions of HYDROQUINONE, HOMOSALATE, OCTISALATE, ZINC OXIDE.
What is the NDC code for Obagi Nu-Derm System Normal-Oily Skin Transformation ?
The NDC (National Drug Code) for Obagi Nu-Derm System Normal-Oily Skin Transformation is 62032-912, listed by Obagi Cosmeceuticals LLC.
Other Hydroquinone, Brands
See all →- Obagi Nu-Derm System Normal-Dry Skin Transformation Kit62032-911
- Obagi-C C-Rx System Normal-Dry Skin Intervention62032-916
- Obagi-C C-Rx System Normal-Oily Skin Intervention62032-915
- Obagi Nu-Derm System Normal-Dry Skin Transformation Trial62032-913
- Obagi Nu-Derm System Normal-Oily Skin Transformation Trial62032-914
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)